Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 602)
Posted On: 10/08/2020 1:40:20 PM
Post# of 155622
Posted By: CTMedic
Re: HCIT #60447
Deaths in the leronlimab arm count as deaths in the leronlimab arm. That is the nature and purpose of double blinded, randomly assorted trials.

The assumption is that people are going to die and that leronlimab has the opportunity to prevent deaths. If the patient died, leronlimab did not prevent the death as hoped and expected.

This is why the important metric is the reduction in mortality rate, with most the predominant expectation that leronlimab will have a 50% reduction in death rate.













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site